Endoscopic measurement of Barrett's esophagus length is unreliable - A prospective comparative biopsy study

Zeitschrift fur Gastroenterologie

Volumn 42, Issue 6, 2004, Pages 499-504

  Egger, K ^a   Meining, A ^a   Werner, M ^a   Hofler H ^a   Classen, M ^a   Rösch, Thomas ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Barrett's esophagus; Endoscopic biopsy; Surveillance endoscopy

Indexed keywords

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CORRELATION FUNCTION; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE;

ADULT; AGED; AGED, 80 AND OVER; ANATOMY, CROSS-SECTIONAL; BARRETT ESOPHAGUS; ESOPHAGOSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 3042741414     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-813061     Document Type: Article

References (27)

1. Hameeteman W, Tytgat GNJ, Houthoff HJ et al. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989; 96: 1249-1256
2. Dent J, Bremner CD, Collen MJ et al. Working party report to the World Congress of Gastroenterology, Sydney, 1990: Barrett's esophagus. J Gastroenterol Hepatol 1991; 6: 1-22
3. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985; 313: 857-859
4. Spechler SJ, Robbins AH, Rubins HB et al. Adenocarcinoma and Barrett's esophagus: an overrated risk? Gastroenterology 1984; 87: 927-933
5. Lambert R. Diagnosis of esophagogastric tumors. Endoscopy 2002; 34: 129-138
6. Koop H. Gastroesophageal reflux disease and Barrett's esophagus. Endoscopy 2002; 34: 97-103
7. Spechler SJ. Endoscopic surveillance of patients with Barrett's esophagus: does the cancer risk justify the practice? Ann Intern Med 1987; 106: 902-904
8. Iftikhar S, James P, Steele R et al. Length of Barrett's esophagus: An important factor in the development of dysplasia and adenocarcinoma. Gut 1992; 33: 1155-1158
9. Sampliner RE. Reduction of acid exposure and regression of Barrett's esophagus. Dig Dis 2000-2001; 18: 203-207
10. Sampliner RE. Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus. Am J Gastroenterol 1994; 89: 1844-1848
11. Neumann CS, Iqbal TH, Cooper BT. Long-term continuous omeprazole treatment of patients with Barrett's esophagus. Aliment Pharmacol Ther 1995; 9: 451-454
12. Wilkinson SP, Biddlestone L, Gore S et al. Regression of columnar-lined (Barrett's) esophagus with omeprazole 40 mg daily: results of 4 years of continuous therapy. Aliment Pharmacol Ther 1999; 13: 1205-1209
13. Malesci A, Savarino V, Zentilin P et al. Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole. Gastrointest Endosc 1996; 44: 700-705
14. Gore S, Healey CJ, Sutton R et al. Regression of columnar lined (Barrett's) esophagus with continuous omeprazole therapy. Aliment Pharmacol Ther 1993; 7: 623-628
15. Peters FT, Ganesh S, Kuipers EJ et al. Endoscopic regression of Barrett's esophagus during omeprazole treatment a randomised double blind study. Gut 1999; 45: 489-494
16. Haag S, Nandrukar S, Talley NJ. Regression of Barrett's esophagus: the role of acid suppression surgery, and ablative methods. Gastrointest Endosc 1999; 50: 229
17. Werner M, Flejou JF, Haunaut P et al. Adenocarcinoma of the esophagus. In: Aaltonen LA, Hamilton S, Kleihues P et al (Hrsg). WHO classification of tumors: pathology and genetics of tumors of the digestive system. Berlin: Springer, 2000: 16-22
18. McClave SA, Boyce HW, Gottfried MR. Early diagnosis of columnar-lined esophagus: a new endoscopic diagnostic criterion. Gastrointest Endosc 1987; 33: 413-416
19. Spechler SJ. Barrett's esophagus. N Engl J Med 2002; 346: 836-842
20. Bar-Meir S. A new endoscopic simulator. Endoscopy 2000; 32: 898-900
21. Menzel J, Domschke W. Gastrointestinal miniprobe sonography: the current status. Am J Gastroenterol 2000; 95: 605-616
22. Egger K, Werner M, Meining A et al. Biopsy surveillance is still necessary in patients with Barrett's oesophagus, despite new endoscopic imaging techniques. Gut 2003; 52: 18-23
23. Kiesslich R, Hahn M, Herrmann G et al. Screening for specialized columnar epithelium with methylene chromoendoscopy in patients with Barrett's esophagus and a normal control group. Gastrointest Endosc 2001; 53: 47-52
24. Canto MI, Setrakian S, Willis J et al. Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus. Gastrointest Endosc 2000; 51: 560-568
25. Gangarosa LM, Halter S, Mertz H. Methylene blue staining and endoscopic ultrasound evaluation of Barrett's esophagus with low grade dysplasia. Dig Dis Sci 2000; 45: 225-229
26. Endo T, Awakawa T, Takahashi H et al. Classification of Barrett's epithelium by magnifying endoscopy. Gastrointest Endosc 2002; 55: 641-647
27. Meining A, Rösch T, Kiesslich R et al. Inter- and intra-observer variability of magnification chromoendoscopy for detecting specialized intestinal metaplasia at the gastroesophageal junction. Endoscopy 2004; 36: 160-164